- Home
- STAA vs NIE Comparison
STAA vs NIE Comparison
Compare STAA & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STAA | NIE |
|---|---|---|
| Founded | 1982 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.9M | 745.4M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | STAA | NIE |
|---|---|---|
| Price | $29.84 | $26.94 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $22.81 | N/A |
| AVG Volume (30 Days) | ★ 965.6K | 64.8K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.04% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $239,442,000.00 | N/A |
| Revenue This Year | $30.82 | N/A |
| Revenue Next Year | $8.41 | N/A |
| P/E Ratio | $292.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.59 | $22.74 |
| 52 Week High | $35.87 | $27.02 |
Technical Indicators
Market Signals| Indicator | STAA | NIE |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 65.39 |
| Support Level | $23.75 | $24.71 |
| Resistance Level | $35.87 | $27.02 |
| Average True Range (ATR) | 1.69 | 0.32 |
| MACD | -0.39 | -0.03 |
| Stochastic Oscillator | 35.16 | 91.92 |
Price Performance
Historical ComparisonAbout STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.